Yoshajandith Vidal-Aguirre
Xalapa De Enriquez, VER 91073, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Antidiabetic drugs in Parkinson's disease.
Journal: Clinical parkinsonism & related disorders
Published: December 05, 2023
Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 25, 2022
Synthesis, in vitro, in silico and in vivo hypoglycemic and lipid-lowering effects of 4-benzyloxy-5-benzylidene-1,3-thiazolidine-2,4-diones mediated by dual PPAR α/γ modulation.
Journal: Bioorganic & medicinal chemistry letters
Published: April 11, 2022
The acute systemic toxicity of thallium in rats produces oxidative stress: attenuation by metallothionein and Prussian blue.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: May 19, 2021
Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson's Disease.
Journal: Neurochemical research
Published: November 23, 2020
Protection induced by estradiol benzoate in the MPP+ rat model of Parkinson's disease is associated with the regulation of the inflammatory cytokine profile in the nigro striatum.
Journal: Journal of neuroimmunology
Published: August 05, 2020
Synergistic antiallodynic and antihyperalgesic interaction between L-DOPA and celecoxib in parkinsonian rats is mediated by NO-cGMP-ATP-sensitive K+ channel.
Journal: European journal of pharmacology
Published: April 03, 2020
The neuroprotective effect of lovastatin on MPP(+)-induced neurotoxicity is not mediated by PON2.
Journal: Neurotoxicology
Published: December 01, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026